Such damage in ME/CFS is accompanied by formation of immunogenic oxidative modified neoepitopes, which, in turn, may cause an IgM-mediated immune response against neoepitopes such as malondialdehyde and azelaic acid (18). Here, CD40LG is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.